Just in time for spring: Scientists find the cellular on and off switch for allergies and asthmaApril 30, 2009New research published in the Journal of Leukocyte Biology finds that a combination of the body's own molecules controls the allergic and asthmatic response If you're one of the millions who dread the spring allergy season, things are looking up. A research study appearing in the May 2009 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) shows how a team of American scientists have identified a previously unknown cellular switch that turns allergies and asthma both on and off. Equally important, this study also suggests that at least for some people with asthma and allergies, their problems might be caused by genes that prevent this switch from working properly. Taken together, this information is an important first step toward new medications that address the root causes of allergies, asthma and other similar diseases. "This study uncovers some of the basic mechanisms that control whether or not people have asthma and allergies and the severity of the symptoms," said John Ryan, Ph.D., Professor of Biology at Virginia Commonwealth University, and a senior scientist involved in the research. "This understanding opens new avenues for treating these and other related diseases." Ryan and colleagues made this discovery in mouse experiments that examined cells from bone marrow and umbilical cord blood that ultimately help create a type of immune cell (mast cells). Too many mast cells lead to an over-aggressive immune response, which causes allergies and asthma. The scientists found that when chemicals (cytokines IL-4 and IL-10) used to initiate an immune response (the "on switch") are added to developing mast cells, the developing cells die. Because bone marrow makes both mast cells and these cytokines, the researchers conclude that just as the cytokines serve as the "on switch" for the immune system, bone marrow cells also use them as the "off switch" to stop mast cells from getting out of hand. Further supporting their discovery was the finding that strains of mice prone to allergies and asthma had genes which affected the production of this chemical "off switch" in their bone marrow. "The immune system has an incredible capacity for balance and counterbalance to maintain optimal and properly tuned immune responses," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology, "The studies by Ryan and colleagues are an excellent example of this inherent self-regulation of the immune system and how an imbalance in mast cell regulation could contribute to allergy and disease." Federation of American Societies for Experimental Biology |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. Women with asthma feel worse Women with asthma are more anxious, find it harder to sleep and are more tired during the day than their male counterparts, but nevertheless tend to be better at following their treatment. Poll: Many parents, high-priority adults who tried to get H1N1 vaccine unable to get it A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. Key player identified in cascade that leads to hypertension-related kidney damage A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||